Please note that we have stopped the regular imports of Gene Expression Omnibus (GEO) data into ArrayExpress. This may not be the latest version of this experiment.
E-GEOD-12093 - Transcription profiling of human breast cancer samples that were treated with tamoxifen identifier a 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
Submitted on 11 July 2008, released on 26 October 2008, last updated on 27 March 2012
Classification of tamixifen-treated breast cancer patients into high and low risk groups using the 76-gene signature Experiment Overall Design: 136 breast cancer samples that were treated with tamoxifen were classified using the 76-gene signature
transcription profiling by array, unknown experiment type
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy. Sieuwerts Zhang, Casey McGreevy, Paradiso Cufer, Span Harbeck, Crowe Hicks, Budd Tubbs, Sweep Lyons, Schittulli Schmitt, Talantov Golouh, Foekens Wang. Breast Cancer Res Treat (2008)